Advertisement

Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry)

      It yet has not been clarified whether there is a late catch-up phenomenon in target lesion revascularization (TLR) after sirolimus-eluting stent (SES) compared to bare metal stent (BMS) implantation. In 12,824 patients enrolled in the j-Cypher Registry, incidences of early (within first year) and late (1 year to 3 years) TLR were compared between 17,050 lesions treated with SESs and 1,259 lesions treated with BMSs. Incidences of TLR in SES-treated lesions were 5.7% at 1 year, 8.1% at 2 years, and 10.0% at 3 years, whereas those in BMS-treated lesions were 14.2%, 15.5%, and 15.5%, respectively (p <0.0001, log-rank test). Incidences of late TLR were significantly higher with SESs compared to BMSs (2.6% vs 1.4% at 2 years and 4.5% vs 1.4% at 3 years, p = 0.0007, log-rank test). A multivariable logistic regression model identified 7 independent risk factors for late TLR at 3 years after SES implantation: hemodialysis, low estimated glomerular filtration rate, ostial right coronary artery, lesion length ≥30 mm, 2 stents for bifurcation, American Heart Association/American College of Cardiology type B2/C, and vessel size <2.5 mm. Of these, 5 factors were common to those for early TLR. In conclusion, a late catch-up phenomenon was observed as indicated by the increasing incidence of late TLR after SES, but not after BMS, implantation. Risk factors for late TLR were generally common to those for early TLR.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mehran R.
        • Dangas G.
        • Abizaid A.S.
        • Mintz G.S.
        • Lansky A.J.
        • Satler L.F.
        • Pichard A.D.
        • Kent K.M.
        • Stone G.W.
        • Leon M.B.
        Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.
        Circulation. 1999; 100: 1872-1878
        • Moses J.W.
        • Leon M.B.
        • Popma J.J.
        • Fitzgerald P.J.
        • Holmes D.R.
        • O'Shaughnessy C.
        • Caputo R.P.
        • Kereiakes D.J.
        • Williams D.O.
        • Teirstein P.S.
        • Jaeger J.L.
        • Kuntz R.E.
        • SIRIUS investigators
        Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
        N Engl J Med. 2003; 349: 1315-1323
        • Stone G.W.
        • Ellis S.G.
        • Cox D.A.
        • Hermiller J.
        • O'Shaughnessy C.
        • Mann J.T.
        • Turco M.
        • Caputo R.
        • Bergin P.
        • Greenberg J.
        • Popma J.J.
        • Russell M.E.
        • TAXUS-IV Investigators
        A polymer-based paclitaxel-eluting stent in patients with coronary artery disease.
        N Engl J Med. 2004; 350: 221-231
        • Claessen B.E.
        • Beijk M.A.
        • Legrand V.
        • Ruzyllo W.
        • Manari A.
        • Varenne O.
        • Suttorp M.J.
        • Tijssen J.
        • Miquel-Hebert K.
        • Veldhof S.
        • Henriques J.
        • Serruys P.W.
        • Piek J.J.
        Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II Trial.
        Circ Cardiovasc Interv. 2009; 2: 339-347
        • Wessely R.
        • Kastrati A.
        • Schömig A.
        Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent.
        Ann Intern Med. 2005; 143: 392-394
        • Cosgrave J.
        • Corbett S.J.
        • Melzi G.
        • Babic R.
        • Biondi-Zoccai G.G.
        • Airoldi F.
        • Chieffo A.
        • Sangiorgi G.M.
        • Montorfano M.
        • Michev I.
        • Carlino M.
        • Colombo A.
        Late restenosis following sirolimus-eluting stent implantation.
        Am J Cardiol. 2007; 100: 41-44
        • Hong M.K.
        • Mintz G.S.
        • Lee C.W.
        • Park D.W.
        • Lee S.W.
        • Kim Y.H.
        • Jung I.H.
        • Kim S.H.
        • Cheong S.S.
        • Kim J.J.
        • Park S.W.
        • Park S.J.
        Late target lesion revascularization after implantation of sirolimus-eluting stent.
        Catheter Cardiovasc Interv. 2008; 71: 299-303
        • Rodriguez A.E.
        • Maree A.O.
        • Mieres J.
        • Berrocal D.
        • Grinfeld L.
        • Fernandez-Pereira C.
        • Curotto V.
        • Rodriguez-Granillo A.
        • O'Neill W.
        • Palacios I.F.
        Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry.
        Eur Heart J. 2007; 28: 2118-2125
        • Kimura T.
        • Morimoto T.
        • Nakagawa Y.
        • Tamura T.
        • Kadota K.
        • Yasumoto H.
        • Nishikawa H.
        • Hiasa Y.
        • Muramatsu T.
        • Meguro T.
        • Inoue N.
        • Honda H.
        • Hayashi Y.
        • Miyazaki S.
        • Oshima S.
        • Honda T.
        • Shiode N.
        • Namura M.
        • Sone T.
        • Nobuyoshi M.
        • Kita T.
        • Mitsudo K.
        • j-Cypher Registry Investigators
        Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
        Circulation. 2009; 119: 987-995
        • Imai E.
        • Horio M.
        • Nitta K.
        • Yamagata K.
        • Iseki K.
        • Hara S.
        • Ura N.
        • Kiyohara Y.
        • Hirakata H.
        • Watanabe T.
        • Moriyama T.
        • Ando Y.
        • Inaguma D.
        • Narita I.
        • Iso H.
        • Wakai K.
        • Yasuda Y.
        • Tsukamoto Y.
        • Ito S.
        • Makino H.
        • Hishida A.
        • Matsuo S.
        Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease.
        Clin Exp Nephrol. 2007; 11: 41-50
        • Cutlip D.E.
        • Windecker S.
        • Mehran R.
        • Boam A.
        • Cohen D.J.
        • van Es G.A.
        • Steg P.G.
        • Morel M.A.
        • Mauri L.
        • Vranckx P.
        • McFadden E.
        • Lansky A.
        • Hamon M.
        • Krucoff M.W.
        • Serruys P.W.
        Clinical end points in coronary stent trials: a case for standardized definitions.
        Circulation. 2007; 115: 2344-2351
        • Kimura T.
        • Yokoi H.
        • Nakagawa Y.
        • Tamura T.
        • Kaburagi S.
        • Sawada Y.
        • Sato Y.
        • Yokoi H.
        • Hamasaki N.
        • Nosaka H.
        • Nobuyoshi M.
        Three-year follow-up after implantation of metallic coronary-artery stents.
        N Engl J Med. 1996; 334: 561-566
        • Kimura T.
        • Abe K.
        • Shizuta S.
        • Odashiro K.
        • Yoshida Y.
        • Sakai K.
        • Kaitani K.
        • Inoue K.
        • Nakagawa Y.
        • Yokoi H.
        • Iwabuchi M.
        • Hamasaki N.
        • Nosaka H.
        • Nobuyoshi M.
        Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries.
        Circulation. 2002; 105: 2986-2991
        • Kastrati A.
        • Schömig A.
        • Elezi S.
        • Schühlen H.
        • Dirschinger J.
        • Hadamitzky M.
        • Wehinger A.
        • Hausleiter J.
        • Walter H.
        • Neumann F.J.
        Predictive factors of restenosis after coronary stent placement.
        J Am Coll Cardiol. 1997; 30: 1428-1436
        • Bauters C.
        • Hubert E.
        • Prat A.
        • Bougrimi K.
        • Van Belle E.
        • McFadden E.P.
        • Amouyel P.
        • Lablanche J.M.
        • Bertrand M.
        Predictors of restenosis after coronary stent implantation.
        J Am Coll Cardiol. 1998; 31: 1291-1298
        • Virmani R.
        • Guagliumi G.
        • Farb A.
        • Musumeci G.
        • Grieco N.
        • Motta T.
        • Mihalcsik L.
        • Tespili M.
        • Valsecchi O.
        • Kolodgie F.D.
        Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?.
        Circulation. 2004; 109: 701-705
        • Higo T.
        • Ueda Y.
        • Oyabu J.
        • Okada K.
        • Nishio M.
        • Hirata A.
        • Kashiwase K.
        • Ogasawara N.
        • Hirotani S.
        • Kodama K.
        Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.
        JACC Cardiovasc Imaging. 2009; 2: 616-624
        • Aoki J.
        • Nakazawa G.
        • Tanabe K.
        • Hoye A.
        • Yamamoto H.
        • Nakayama T.
        • Onuma Y.
        • Higashikuni Y.
        • Otsuki S.
        • Yagishita A.
        • Yachi S.
        • Nakajima H.
        • Hara K.
        Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.
        Catheter Cardiovasc Interv. 2007; 69: 380-386
        • Fajadet J.
        • Morice M.C.
        • Bode C.
        • Barragan P.
        • Serruys P.W.
        • Wijns W.
        • Constantini C.R.
        • Guermonprez J.L.
        • Eltchaninoff H.
        • Blanchard D.
        • Bartorelli A.
        • Laarman G.J.
        • Perin M.
        • Sousa J.E.
        • Schuler G.
        • Molnar F.
        • Guagliumi G.
        • Colombo A.
        • Ban Hayashi E.
        • Wülfert E.
        Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
        Circulation. 2005; 111: 1040-1044
        • Weisz G.
        • Leon M.B.
        • Holmes Jr, D.R.
        • Kereiakes D.J.
        • Popma J.J.
        • Teirstein P.S.
        • Cohen S.A.
        • Wang H.
        • Cutlip D.E.
        • Moses J.W.
        Five-year follow-up after sirolimus-eluting stent implantation: results of the SIRIUS trial.
        J Am Coll Cardiol. 2009; 53: 1488-1497